NCT03597568View on ClinicalTrials.gov

Resveratrol and Vascular Function in CKD

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 12, 2023

Study Completion Date

January 12, 2023

Conditions
Chronic Kidney DiseasesEndothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

Resveratrol

Oral supplementation for 6 weeks

OTHER

Placebo

Oral supplementation for 6 weeks

Trial Locations (1)

52245

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

Diana Jalal

OTHER

NCT03597568 - Resveratrol and Vascular Function in CKD | Biotech Hunter | Biotech Hunter